
Acenor Mr Tab
R.B.Pharmaceuticals - Tablet - 10 S
Save ₹5
Prescription required
Empagliflozin 25 mg + Linagliptin 5 mg
Delivery across India. Free above ₹999; ₹49 from ₹499, ₹99 below. Chennai express delivery is chargeable.
This medicine needs a prescription.
You can pay now and add the prescription afterwards. We pack your order only after a pharmacist verifies it.
A doctor decides whether a prescription can be issued. If it is not issued, the prescription items in your order are cancelled and refunded. You choose this at checkout.
Empaben L 25/5 mg Tablet is used for type 2 diabetes mellitus: to improve glycaemic control in adults as an adjunct to diet and exercise, when treatment with empagliflozin and linagliptin is appropriate (including add-on to other antidiabetic medicines).
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated September 2026
Medicines with the same active ingredient and strength as Empaben L 25/5 mg Tablet.
You are viewing
Empaben L 25/5 mg Tablet
tablet - 25mg + 5mg - 10 S
₹185
₹18.53 per tablet
VERSE LIFESCIENCES · tablet - 25mg + 5mg - 10 S · Rx
₹106
₹10.60 per tablet
Macleods Pharmaceuticals Pvt Ltd · tablet - 25mg + 5mg - 10 S · Rx
₹113
₹11.27 per tablet
HBC LIFESCEINCE PVT LTD · tablet - 25mg + 5mg - 10 S · Rx
₹115
₹11.49 per tablet
A substitute contains the same active ingredient (salt), in the same strength, as Empaben L 25/5 mg Tablet. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Empaben L 25/5 mg Tablet contains Empagliflozin 25 mg + Linagliptin 5 mg. It belongs to the SGLT2 inhibitor + DPP-4 inhibitor combination class of medicines.
Empagliflozin is an SGLT2 inhibitor that lowers blood glucose by increasing urinary glucose excretion via the kidneys. Linagliptin is a DPP-4 inhibitor that increases incretin levels (GLP-1, GIP), enhancing insulin secretion and reducing glucagon release in a glucose-dependent manner.
Oral tablet. Typically taken once daily at the same time each day, with or without food, as prescribed by a doctor. Swallow whole with water; do not crush/chew. Maintain hydration and follow diet/exercise advice.
Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.
Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.
An overdose of this medicine can cause dehydration and a fall in blood pressure. It may cause low blood sugar, particularly if you also take other diabetes medicines. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.
Most side effects of Empaben L 25/5 mg are mild and settle as the body adjusts. Reported side effects include:
Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.
| Pregnancy | Not recommended; consult doctor (insufficient data, avoid SGLT2 inhibitors in later pregnancy). |
|---|---|
| Breastfeeding | Not recommended while breastfeeding. |
| Alcohol | Use with caution; alcohol may increase risk of dehydration and ketoacidosis and can affect blood sugar control. |
| Driving | May cause drowsiness or affect your concentration. Do not drive until you know how it affects you. |
| Kidney | Consult your doctor if you have kidney disease. |
| Liver | Use with caution if you have liver disease — your doctor may adjust the dose or monitor your liver function. |
| Habit forming | No |
Prescription-only antidiabetic. Risk of dehydration/low blood pressure (especially elderly or on diuretics); maintain adequate fluids. SGLT2 inhibitors may rarely cause ketoacidosis—seek urgent care for nausea/vomiting, abdominal pain, fast breathing, unusual tiredness. Increased risk of genital mycotic infections and UTIs; maintain hygiene and report symptoms. Temporarily stop before major surgery/acute serious illness as advised. Use caution in kidney impairment; empagliflozin efficacy reduces with low eGFR and may be contraindicated in severe renal failure—doctor to monitor renal function. Rare risk of pancreatitis with DPP-4 inhibitors; stop and consult if severe abdominal pain. Not indicated for type 1 diabetes.
Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for type 1 diabetes or for diabetic ketoacidosis. Not for people with severe kidney disease.
Diuretics (increased dehydration/hypotension), insulin or sulfonylureas (increased hypoglycaemia risk), rifampicin (may reduce linagliptin effect), strong inducers of P-gp/CYP3A4 (may reduce linagliptin exposure), other antidiabetic agents (additive glucose-lowering), alcohol (may increase dehydration/ketoacidosis risk)
Store below 25°C, protected from moisture and direct light. Keep in original blister pack. Keep out of reach of children.
Take it in the morning so the extra urine does not disturb your sleep. Keep up your fluid intake and maintain genital hygiene. Tell any doctor treating you for an acute illness that you take this medicine. It can be taken with or without food, at the same time each day. Keep up your diet and activity — this medicine supports them.
Medicines with the same active ingredient (Empagliflozin 25 mg + Linagliptin 5 mg). Ask your doctor or pharmacist before switching brands.
| Medicine | Pack | Price | vs Empaben L 25/5 mg Tablet |
|---|---|---|---|
| Empaverse L 25/5 mg TabletVERSE LIFESCIENCES | tablet · 10`S | ₹106 | 43% cheaper |
| Empahope L 25 TabletMacleods Pharmaceuticals Pvt Ltd | tablet · 10`S | ₹113 | 39% cheaper |
| Empatru L 25/5 mg TabletHBC LIFESCEINCE PVT LTD | tablet · 10`S | ₹115 | 38% cheaper |
| Empha-L 25 mg TabletIntas Pharmaceuticals Ltd | tablet · 10`S | ₹136 | 27% cheaper |
| Linabite E 5/10 mg TabletCorona Remedies Pvt Ltd | tablet · 10`S | ₹137 | 26% cheaper |
| Empatrol-L 25/5 mg TabletARISTO PHARMACEUTICALS PVT LTD | tablet · 10`S | ₹147 | 21% cheaper |
| Empadus-25L TabletLIVIDUS PHARMACEUTICALS PVT LTD.` | tablet · 10`S | ₹151 | 18% cheaper |
| Linapride-E 5/25 mg TabletMICRO LABS | tablet · 10`S | ₹158 | 15% cheaper |
| Linacip E 5/25 mg TabletCIPLA LIMITED | tablet · 10`S | ₹169 | 9% cheaper |
| Auroempa 25 mg TabletVEITAZ HEALTHCARE LIMITED | tablet · 10`S | ₹187 | 1% more |
| Empalion-L30 TabletSTALLION LABORATORIES PVT LTD | tablet · 10`S | ₹191 | 3% more |
| Gludrain S 25/100 mg TabletNEUCURE HEALTHCARE PVT LTD | tablet · 10`S | ₹205 | 11% more |

R.B.Pharmaceuticals - Tablet - 10 S
Save ₹5
Prescription required

R.B.Pharmaceuticals - Tablet - 10 S
Save ₹3
Prescription required

R.B.Pharmaceuticals - Tablet - 10 S
Save ₹6
R.B.Pharmaceuticals - Tablet - 10 S
Save ₹14

R.B.Pharmaceuticals - 100 ml
Save ₹6
Prescription required

R.B.Pharmaceuticals - Tablet - 4 gm - 10 S
Save ₹13

R.B.Pharmaceuticals - Tablet - 10 S
Save ₹6

R.B.Pharmaceuticals - Tablet - 30 S
Save ₹29

IPCA Laboratories Ltd - 10 S
Save ₹12
Prescription required

Lloyd Healthcare - Tablet - 40mg + 10mg - 10 S
Save ₹10
Prescription required

Shrrishti Healthcare Products(I) Pvt Ltd - Tablet - 500mg + 10mg - 10 S
Save ₹5
Prescription required

Micro Labs - Tablet - 2mg + 1000mg + 10mg - 10 S
Save ₹8
Prescription required
Lupin Lab - 3 ml
Save ₹74
Prescription required
Lividus Pharmaceuticals Pvt Ltd. - Tablet - 10mg + 5mg - 10 S
Save ₹7
Prescription required

Alkem Lab - Tablet - 500mg + 60mg - 10
Save ₹8
Prescription required
Cipla Limited - Tablet - 10 Tablet
Save ₹20
Prescription required
Common Products - Tablet - 4 Tablet
Save ₹22
Prescription required

Pfizer Ltd - Tablet - 15 Tablet
Save ₹1
Prescription required

D9 Healthcare Llp - Kit
Save ₹83
12 G
1*1
Save ₹90
100 S
Funplay - 1*3*30
Save ₹2
1
Save ₹52
The information on Empaben L 25/5 mg Tablet is compiled from the manufacturer's prescribing information and the sources below, and is reviewed by a registered medical practitioner. It does not replace advice from your own doctor.